metformin has been researched along with deoxyguanosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benarroch, M; Gornitsky, M; Salah, MH; Schipper, HM; Su, H; Trifiro, M; Velly, AM | 1 |
| Kim, CS; Kim, J; Kim, JS; Shon, E | 1 |
| Ahmet, D; Cigdem, E; Ece, H; Hakan, E; Oktay, TM; Yuksel, K | 1 |
3 other study(ies) available for metformin and deoxyguanosine
| Article | Year |
|---|---|
Altered redox homeostasis in human diabetes saliva.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Age Factors; Biomarkers; Deoxyguanosine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Dinoprost; DNA Damage; Homeostasis; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Metformin; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Saliva; Salivary Proteins and Peptides; Sex Factors | 2012 |
Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Animals; Antioxidants; Apoptosis; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; DNA Fragmentation; Hypoglycemic Agents; Kidney; Male; Metformin; Microfilament Proteins; Oxidative Stress; Podocytes; Random Allocation; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley | 2012 |
Use of oral antidiabetic drugs (metformin and pioglitazone) in diabetic patients with breast cancer: how does it effect serum Hif-1 alpha and 8Ohdg levels?
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Blood Glucose; Breast Neoplasms; Case-Control Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Metformin; Pioglitazone; Prognosis; Thiazolidinediones | 2012 |